Home > Insider Trading > Filing (0001209191-21-062705)

Filing Details

Accession Number:: 0001209191-21-062705
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-03 16:30:57
Reporting Period:: 2021-11-01

Accepted Time:: 2021-11-03 16:30:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Therapeutics Public Ltd Co	HZNP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1349376	P Timothy Walbert	C/O Horizon Therapeutics Plc, 70 Saint Stephen?S Green Dublin L2 D02 E2X4	Chairman, President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2021-10-26	100,300	$0.00	31,196	No	5	G	Indirect	By spouse
Ordinary Shares	Acquisiton	2021-10-26	100,300	$0.00	100,300	No	5	G	Indirect	See footnote
Ordinary Shares	Disposition	2021-11-01	7,801	$117.31	571,681	No	4	S	Direct
Ordinary Shares	Disposition	2021-11-01	6,829	$118.46	564,852	No	4	S	Direct
Ordinary Shares	Disposition	2021-11-01	9,733	$119.36	555,119	No	4	S	Direct
Ordinary Shares	Disposition	2021-11-01	637	$120.09	554,482	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Indirect	By spouse
No	5	G	Indirect	See footnote
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	107,739	Indirect	See footnote

Footnotes

The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2021.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.96 to $117.95 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.99 to $118.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.985 to $119.97 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.99 to $120.32 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.